GlaxoSmithKline PLC

15 Minute Delayed Share Price Glossary Go to Portfolio
Current Chg % Chg Open High Low Volume
1,218.50
-0.50
-0.04% 1,218.50 1,227.05 1,212.50 12.73m

Share Price Chart

label: share priceshare price chart showing price and earning per share against datelabel: earning per share

Broker Recommendation (11 Brokers)

STRONG SELL STRONG BUY
HOLD
Key Figures
Market Cap. £63,282.04m PER (pr) 10.1x EPS Growth (pr) 11.5% ROCE/ROIC 38.65%
Shares in issue 5191.31m PEG (pr) 0.88f DY (pr) 5.39% Net Gearing 133%
Company Background
Sector Health
Activities Engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical and health-related consumer products
TIDM GSK
Index FTSE 100, FTSE 350, S&P Europe 350, FTSE Eurotop 100, Eurotop 300, FTSE All Share, FTSE Techmark All Share
Listed LSE - Full

Outlook

(4/2/2010) PLM: ceo - "...I am confident of our prospects in 2010"
Latest Results
Prelim 31/12/2008 31/12/2009
Turnover £m 24352 28368
Pre-tax Profit £m 6659 7891
EPS (Norm Dil.) p 103.99 106.28
Dividend p 55 59
Notes Figures from 2004 in accordance with IFRS
Investment Ratios
  Co. FTSE Sector Market
PER (pr) x 10.14 10.17 11.02
Dividend Yield (pr) % 5.39 4.97 4.05
PEG (pr) f 0.88 -0.79 -0.40
ROCE % 38.65 53.33 124.67
Operating Margin % 32.64 21.54 9.32
EPS Growth (pr) % 11.52 11.94 16.64
EV/EBITDA x 8.16 7.52 6.94
Net Gearing % 133.20 93.61 150.58
Net Tangible Asset Value PS p -1.09 1.20
Price to Tangible Book Value (PTBV) x -5.37 0.56
Price to Cashflow (PCF) x 11.90 9.70
Price to Sales Ratio (PSR) x 4.71 2.16
Definitions | Disclaimer
Data provided by Morningstar.
© Copyright 2009 Morningstar. All rights reserved. Please read our Terms of Use and Privacy Policy.